Pacific Edge shares tumble 14% after FY net loss

Pacific Edge shares tumble 14% after FY net loss
Rebecca Howard
By Rebecca Howard May 29 (BusinessDesk) - Pacific Edge's shares fell 14 percent, despite reporting a smaller full year net loss as more people adopted its Cxbladder cancer diagnostics tests. The shares dropped to 18.5 cents after the Dunedin-based company reported a loss of $17.9 million in the year to March 31, versus a loss of $19.7 million in the prior year. Operating revenue from test sales was up 12 percent to $3.8 million while total revenue was up 3 percent to $5.1 million.  The company has developed non-invasive, accurate and s...

More Services

Creative solutions needed to keep NZ workers
Economy

Creative solutions needed to keep NZ workers

Robert Walters sees talent migration potentially getting worse in 2025.

‘Battle-hardened’ Trade Window eyes growth
Markets

‘Battle-hardened’ Trade Window eyes growth

The customs software minnow has weathered the storm. What next?

Pattrick Smellie 21 Nov 2024
Crimson big enough for ASX IPO: Beaton
Finance

Crimson big enough for ASX IPO: Beaton

A US market listing at a greater scale looks more likely.

Pattrick Smellie 06 Nov 2024
CoreLogic data suggests property market floor is nigh
Property

CoreLogic data suggests property market floor is nigh

Broad economic trends underpin the latest figures, CoreLogic's economist says.